Market Insights

The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer's and a precursor condition, mild cognitive impairment.

As our market evolves, products multiply, and available tools like AI are incorporated into our process, we need to incorporate a learning mindset into our operations.

The Equal Employment Opportunity Commission (EEOC) has provided guidance that AI programs will trigger Title VII discrimination violations when protected classes are disfavored in employment selection processes.

The survey noted that the vast majority of plans (87%) do not cover "new" drug therapies.

The amount 401(k) participants say they need to retire comfortably inched up this year, while confidence in their ability to attain retirement goals dropped amid economic pressures.

Colliers writes that lower cost and greater convenience are key benefits for all.